VICTORY CAPITAL MANAGEMENT INC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1040188 San Antonio, TX

Position in PTGX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$10,282,378

+$1,476,841 QoQ

Shares Held

83,883

+0.4% QoQ

Ownership

0.130%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#75

of 341 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. PTGX ranks #26 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,282,378	83,883	+0.4%	Shares	Sole	2026-08-07
2026-03-31	$8,805,537	83,544	+3.7%	Shares	Sole	2026-05-15
2025-12-31	$7,037,071	80,571	-5.8%	Shares	Sole	2026-02-13
2025-09-30	$5,679,366	85,494	-6.0%	Shares	Sole	2025-11-12
2025-06-30	$5,025,811	90,932	-11.2%	Shares	Sole	2025-08-13
2025-03-31	$4,952,595	102,411	-57.5%	Shares	Sole	2025-05-02
2024-12-31	$9,295,536	240,817	+84.1%	Shares	Sole	2025-02-06
2024-09-30	$5,885,865	130,797	+1729.3%	Shares	Other	2024-11-05
2024-06-30	$247,747	7,150	-0.8%	Shares	Sole	2024-08-05
2024-03-31	$208,527	7,208	-25.0%	Shares	Sole	2024-05-03
2021-12-31	$328,730	9,612	-98.9%	Shares	Sole	2022-02-07
2021-06-30	$37,932,530	845,199	+25311.9%	Shares	Sole	2021-08-03
2020-03-31	$23,481	3,326	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.